Abreva

Abreva is an over-the-counter cold sore treatment brand. Its principal product is a topical treatment containing 10% docosanol, intended for cold sores on the lips and face associated with herpes simplex virus. It is generally positioned for use at the first sign of symptoms to help shorten healing time. The brand was formerly part of GlaxoSmithKline’s consumer healthcare business and is now associated with Haleon following the formation of that company from the consumer healthcare businesses of GSK and Pfizer. Reliable public information is insufficient to establish an independent founding date or a broader product portfolio.

Abreva’s core offering is an over-the-counter topical cold sore treatment containing 10% docosanol. The active ingredient is used in a topical product designed for consumer treatment of cold sores in a home setting. Public information has commonly associated the brand with GlaxoSmithKline’s consumer healthcare business. In 2022, GSK’s consumer healthcare business combined with Pfizer’s consumer healthcare business to form Haleon, which began operating as an independent consumer healthcare company; Abreva became part of Haleon’s brand portfolio. Available material is insufficient to confirm the brand’s founding year, founder, complete international market coverage, or a more extensive historical chronology.

• 2022

  Transition to Haleon brand portfolio

  [1]Haleon starts trading as a new world-leading consumer healthcare companyhaleon.com

  Following the demerger of GSK's consumer healthcare business and its merger with Pfizer's consumer healthcare business to form Haleon, Abreva became a consumer healthcare brand under Haleon.

Over-the-counter topical treatment brand for cold sores

• Over-the-counter topical medication

  Abreva Cold Sore Treatment

  Abreva’s core topical over-the-counter treatment for cold sores on the lips and face. Its principal active ingredient is 10% docosanol, and the product is positioned for use at the early signs of a cold sore.

1. 1Haleon starts trading as a new world-leading consumer healthcare companyhaleon.com
2. 2Abreva official websiteabreva.com